LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Relative Growth Rate After Treatment
BT-20 Dasatinib
3.33
uM
LJP6
 72
hr
 1334 988 3970 0.2488 -0.1315
BT-20 Dovitinib
3.33
uM
LJP5
 72
hr
 1334 1816 3970 0.4574 0.1827
BT-20 Enzastaurin
3.33
uM
LJP5
 72
hr
 1334 4320 3970 1.0880 1.1325
BT-20 Erlotinib
3.33
uM
LJP5
 72
hr
 1334 3753 3970 0.9451 0.9173
BT-20 Foretinib
3.33
uM
LJP5
 72
hr
 1334 1038 3970 0.2615 -0.1124
BT-20 R406
3.33
uM
LJP6
 72
hr
 1334 4100 3970 1.0327 1.0492
BT-20 Pictilisib
3.33
uM
LJP6
 72
hr
 1334 1726 3970 0.4348 0.1487
BT-20 Gefitinib
3.33
uM
LJP6
 72
hr
 1334 3702 3970 0.9323 0.8980
BT-20 Geldanamycin
3.33
uM
LJP5
 72
hr
 1334 870 3970 0.2193 -0.1760
BT-20 Geldanamycin
3.33
uM
LJP6
 72
hr
 1334 812 3970 0.2046 -0.1981
BT-20 GSK1059615
3.33
uM
LJP5
 72
hr
 1334 428 3970 0.1079 -0.3438
BT-20 GSK1059615
3.33
uM
LJP6
 72
hr
 1334 626 3970 0.1578 -0.2686
BT-20 GSK1904529A
3.33
uM
LJP6
 72
hr
 1334 3893 3970 0.9805 0.9706
BT-20 Omipalisib
3.33
uM
LJP6
 72
hr
 1334 566 3970 0.1425 -0.2916
BT-20 GSK 690693
3.33
uM
LJP5
 72
hr
 1334 2401 3970 0.6047 0.4046
BT-20 GW843682X
3.33
uM
LJP6
 72
hr
 1334 1015 3970 0.2556 -0.1213
BT-20 HG-5-113-01
3.33
uM
LJP5
 72
hr
 1334 1876 3970 0.4726 0.2056
BT-20 HG-5-88-01
3.33
uM
LJP6
 72
hr
 1334 3499 3970 0.8812 0.8211
BT-20 Imatinib
3.33
uM
LJP6
 72
hr
 1334 3926 3970 0.9889 0.9832
BT-20 JNK-9L
3.33
uM
LJP6
 72
hr
 1334 1845 3970 0.4646 0.1936
BT-20 JW-7-24-1
3.33
uM
LJP6
 72
hr
 1334 3351 3970 0.8441 0.7651
BT-20 Lapatinib
3.33
uM
LJP6
 72
hr
 1334 4171 3970 1.0504 1.0759
BT-20 LDN-193189
3.33
uM
LJP5
 72
hr
 1334 1491 3970 0.3755 0.0593
BT-20 Linifanib
3.33
uM
LJP6
 72
hr
 1334 4058 3970 1.0221 1.0333
BT-20 Linsitinib
3.33
uM
LJP5
 72
hr
 1334 3836 3970 0.9661 0.9490